Trials / Completed
CompletedNCT00004770
Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (planned)
- Sponsor
- National Center for Research Resources (NCRR) · NIH
- Sex
- Male
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
OBJECTIVES: I. Assess the efficacy of thioctic acid in treating a single patient with mitochondrial myopathy.
Detailed description
PROTOCOL OUTLINE: The patient receives one thioctic acid tablet 3 times a day. If patient experiences no side effects after 1 week, 2 tablets are administered and given 3 times a day over 3 months for compassionate use. The patient is followed at weeks 3, 8, and 12.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | thioctic acid |
Timeline
- Start date
- 1995-10-01
- First posted
- 2000-02-25
- Last updated
- 2005-06-24
Source: ClinicalTrials.gov record NCT00004770. Inclusion in this directory is not an endorsement.